BrevierHealth BrevierHealth
← Índice de calculadoras

Migraine Treatment Optimization Questionnaire-4 (mTOQ-4)

Código: 10496 · migraine_treatment_optimization_questionnaire_mtoq_4

Determines effectiveness of current migraine treatment plan.

Prognosis

Referencias

Original/Primary Reference

  1. Lipton RB, Kolodner K, Bigal ME, et al. Validity and reliability of the migraine-treatment optimization questionnaire. Cephalalgia. 2009;29(7):751-759. ↗

Other References

  1. Serrano D, Buse DC, Manack Adams A, Reed ML, Lipton RB. Acute treatment optimization in episodic and chronic migraine: results of the American Migraine Prevalence and Prevention (Ampp) Study. Headache. 2015;55(4):502-518. ↗
  2. Lipton RB, Munjal S, Buse DC, Fanning KM, Bennett A, Reed ML. Predicting inadequate response to acute migraine medication: results from the american migraine prevalence and prevention (Ampp) study. Headache. 2016;56(10):1635-1648. ↗
  3. Ailani J, Burch RC, Robbins MS, Board of Directors of the American Headache Society. The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice. Headache. 2021;61(7):1021-1039. ↗
  4. Mack KJ, Digre K. Effectiveness in acute migraine treatment: how it might matter. Neurology. 2015;84(7):641-642. ↗

Validation

  1. Lipton RB, Fanning KM, Serrano D, Reed ML, Cady R, Buse DC. Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine. Neurology. 2015;84(7):688-695. ↗